Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic Anemia
Robert P. Witherspoon(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), E. Donnall Thomas(AbbVie (United States)), Gary Schoch(University of Washington), K Doney(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jean E. Sanders(Carolinas Medical Center), H. Joachim Deeg(University of Washington), Rainer Storb(University of Washington), Paul S. Martin(University of Washington), David B. Thomas(University of Washington), Lloyd D. Fisher(University of Washington), Keith M. Sullivan(National Cancer Institute)
Cited by 421
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Antileukemic Effect of Chronic Graft-versus-Host Disease
|New England Journal of Medicine|1981|1.1k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968